The Immunogenicity University full-day summit is back by popular demand! This popular full-day intensive skill-builder returns to the 2013 program, with an all-new speaker faculty and case studies to streamline all of your day-to-day problems with immunoassay design, validation and transfer.Experts at all career stages will benefit from these in-depth sessions that emphasize troubleshooting, improving result quality and turnover time, and matching the expectations of regulatory reviewers.
- •Fundamentals of Immunogenicity Assessment presented by Holly Smith, Principal Research Scientist, Investigative Toxicology, ELI LILLY
- • Ongoing Assay Design and Modification Choices Throughout the Drug Development Life Cycle presented by Joseph Bower, Executive Director - Immunochemistry, COVANCE
- • Optimal Formats for Identifying and Quantifying NAb Response presented by Martin Lechmann, Associate Director, DMPK, MERCK SERONO and Thomas Lee, Scientific Investigator, Clinical Immunology, GLAXOSMITHKLINE
Download the full agenda for all the 2013 event details.
The Immunogenicity for Biotherapeutics Conference is taking place March 18-20, 2013, in Baltimore, MD. As a reader of this blog,when you register to join us and mention code XP1838BLOG, you save 15% off the standard rate! If you have any questions, email Jennifer Pereira.
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment